North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
- Citation:
- Ann Oncol vol 21 (2) 269-274
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA25224
- Corr. Author:
- Authors:
- E. A. Perez D. W. Hillman T. Dentchev N. A. Le-Lindqwister L. H. Geeraerts T. R. Fitch H. Liu D. L. Graham S. P. Kahanic H. M. Gross T. A. Patel F. M. Palmieri A. C. Dueck
- Networks:
- Study
- NCCTG-N0432
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- bevacizumab, capecitabine, chemotherapy, docetaxel